Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Vaccines | 2 | 2020 | 177 | 1.220 |
Why?
|
| Neuroblastoma | 2 | 2020 | 528 | 0.950 |
Why?
|
| Vaccines, DNA | 2 | 2020 | 48 | 0.840 |
Why?
|
| Salmonella Vaccines | 1 | 2020 | 7 | 0.690 |
Why?
|
| Vaccines, Conjugate | 1 | 2020 | 78 | 0.670 |
Why?
|
| Drug Carriers | 1 | 2020 | 100 | 0.660 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 386 | 0.570 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 1160 | 0.440 |
Why?
|
| Polyethyleneimine | 2 | 2020 | 10 | 0.350 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2020 | 54 | 0.170 |
Why?
|
| Salmonella typhimurium | 1 | 2020 | 43 | 0.170 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 131 | 0.170 |
Why?
|
| Vaccines, Attenuated | 1 | 2020 | 175 | 0.170 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 308 | 0.170 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 216 | 0.160 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2019 | 26 | 0.160 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 206 | 0.160 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2020 | 106 | 0.160 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2019 | 106 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2020 | 505 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 555 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2020 | 680 | 0.120 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3396 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2020 | 2604 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4409 | 0.080 |
Why?
|
| Animals | 2 | 2020 | 34349 | 0.080 |
Why?
|
| Mice | 1 | 2020 | 17727 | 0.050 |
Why?
|
| Lymphopenia | 1 | 2019 | 36 | 0.040 |
Why?
|
| Adenovirus Infections, Human | 1 | 2019 | 50 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2019 | 145 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 359 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2019 | 174 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2019 | 190 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 672 | 0.030 |
Why?
|
| Female | 2 | 2020 | 66998 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2019 | 281 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 534 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1420 | 0.030 |
Why?
|
| Male | 1 | 2020 | 61776 | 0.030 |
Why?
|
| Humans | 2 | 2020 | 125667 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1204 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 1727 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 5893 | 0.020 |
Why?
|
| Child | 1 | 2019 | 24559 | 0.010 |
Why?
|